Manisan, Roselyn S.
HRN: 24-24-77 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/19/2023
CEFUROXIME 750MG (VIAL)
12/19/2023
12/26/2023
IV
1.5g
Q8 X 6 Doses
S/P LTCS With BTL
Waiting Final Action
Indication: Prophylaxis Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes